Connection

Alexandre Mebazaa to Risk Assessment

Back to Details
This is a "connection" page, showing publications Alexandre Mebazaa has written about Risk Assessment.
Alexandre Mebazaa
Connection Strength
0.102
Risk Assessment
  1. Morphine Use in the ED and Outcomes of Patients With Acute Heart Failure: A Propensity Score-Matching Analysis Based on the EAHFE Registry. Chest. 2017 10; 152(4):821-832.
    View in: PubMed
    Score: 0.031
  2. Proenkephalin, Renal Dysfunction, and Prognosis in Patients With Acute Heart Failure: A GREAT Network Study. J Am Coll Cardiol. 2017 Jan 03; 69(1):56-69.
    View in: PubMed
    Score: 0.030
  3. Protein-based cardiogenic shock patient classifier. Eur Heart J. 2019 08 21; 40(32):2684-2694.
    View in: PubMed
    Score: 0.009
  4. Prediction of major adverse kidney events in critically ill burn patients. Burns. 2018 12; 44(8):1887-1894.
    View in: PubMed
    Score: 0.008
  5. Performance of Prognostic Risk Scores in Chronic Heart Failure Patients Enrolled in the European Society of Cardiology Heart Failure Long-Term Registry. JACC Heart Fail. 2018 06; 6(6):452-462.
    View in: PubMed
    Score: 0.008
  6. Combined Measurement of Soluble ST2 and Amino-Terminal Pro-B-Type Natriuretic Peptide Provides Early Assessment of Severity in Cardiogenic Shock Complicating Acute Coronary Syndrome. Crit Care Med. 2017 Jul; 45(7):e666-e673.
    View in: PubMed
    Score: 0.008
  7. Prognostic stratification in pulmonary hypertension: A multi-biomarker approach. Rev Port Cardiol. 2017 Feb; 36(2):111-125.
    View in: PubMed
    Score: 0.008
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.